Since the isolation of CD34+ “putative EPCs” from peripheral blood mononuclear cells [1], many clinical studies reported that CD34+ cell therapy could treat cardiovascular diseases [20, 28]. The gene discussed is CD34; the disease is cardiovascular disorder.